New York Medical College, Valhalla, CA, United States.
Division of Pulmonary, Critical Care, and Sleep Medicine, School of Medicine, University of California San Diego, La Jolla, CA, United States.
JMIR Mhealth Uhealth. 2020 May 21;8(5):e16147. doi: 10.2196/16147.
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death by disease worldwide and has a 30-day readmission rate of 22.6%. In 2015, COPD was added to the Medicare Hospital Readmission Reductions Program.
The objective of this paper was to survey the current medical technologies for remote patient monitoring (RPM) tools that forecast COPD exacerbations in order to reduce COPD readmissions.
We searched literature and digital health news to find commercially available RPM devices focused on predicting COPD exacerbations. These technologies were reviewed and compared according to four criteria: forecasting ability, cost, ease of use, and appearance. A rating system was developed to facilitate the evaluation process.
As of June 2019, a list of handheld and hands-free devices was compiled. We compared features and found substantial variations. Devices that ranked higher on all criteria tended to have a high or unlisted price. Commonly mass-marketed devices like the pulse oximeter and spirometer surprisingly fulfilled the least criteria.
The COPD RPM technologies with most technological promise and compatibility with daily living appear to have high or unlisted prices. Consumers and providers need better access to product information to make informed decisions.
慢性阻塞性肺疾病（COPD）是全球第三大死因疾病，30 天再入院率为 22.6%。2015 年，COPD 被纳入医疗保险医院再入院率降低计划。
本文旨在调查当前用于远程患者监测（RPM）工具的医疗技术，以预测 COPD 恶化，从而降低 COPD 的再入院率。
我们检索文献和数字健康新闻，以找到专注于预测 COPD 恶化的商业可用 RPM 设备。根据预测能力、成本、易用性和外观四个标准对这些技术进行了回顾和比较。开发了一个评级系统来简化评估过程。
截至 2019 年 6 月，编制了一份手持式和免提式设备清单。我们比较了功能，发现存在很大差异。在所有标准上得分较高的设备往往价格较高或未列出。像脉搏血氧仪和肺活量计这样常见的大众市场设备令人惊讶地只满足了最少的标准。
具有最先进技术和与日常生活兼容性的 COPD RPM 技术似乎价格较高或未列出。消费者和提供者需要更好地获取产品信息，以便做出明智的决策。
